BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34594324)

  • 1. Novel Immune Infiltrating Cell Signature Based on Cell Pair Algorithm Is a Prognostic Marker in Cancer.
    Zhang H; Wang Z; Dai Z; Wu W; Cao H; Li S; Zhang N; Cheng Q
    Front Immunol; 2021; 12():694490. PubMed ID: 34594324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment.
    Zhang N; Zhang H; Wang Z; Dai Z; Zhang X; Cheng Q; Liu Z
    Front Immunol; 2021; 12():691811. PubMed ID: 34489938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
    Hu Y; Tu Z; Lei K; Huang K; Zhu X
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single cell RNA sequencing reveals differentiation related genes with drawing implications in predicting prognosis and immunotherapy response in gliomas.
    Zhou Z; Wei J; Yang Z; Bao Y; Jiang W; Lu B; Wang W; Li L
    Sci Rep; 2022 Feb; 12(1):1872. PubMed ID: 35115572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis.
    Zhao B; Wang Y; Wang Y; Dai C; Wang Y; Ma W
    Front Immunol; 2021; 12():557994. PubMed ID: 34220791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma.
    Xu S; Tang L; Liu Z; Luo C; Cheng Q
    Front Immunol; 2021; 12():731048. PubMed ID: 34659218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITGB2 as a prognostic indicator and a predictive marker for immunotherapy in gliomas.
    Xu H; Zhang A; Han X; Li Y; Zhang Z; Song L; Wang W; Lou M
    Cancer Immunol Immunother; 2022 Mar; 71(3):645-660. PubMed ID: 34313821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six Immune Associated Genes Construct Prognostic Model Evaluate Low-Grade Glioma.
    Tan YQ; Li YT; Yan TF; Xu Y; Liu BH; Yang JA; Yang X; Chen QX; Zhang HB
    Front Immunol; 2020; 11():606164. PubMed ID: 33408717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and predictive value of an immune infiltration signature in diffuse lower-grade gliomas.
    Song LR; Weng JC; Li CB; Huo XL; Li H; Hao SY; Wu Z; Wang L; Li D; Zhang JT
    JCI Insight; 2020 Mar; 5(8):. PubMed ID: 32229719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.
    Zhang C; Li J; Wang H; Song SW
    Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel immune cell signature for predicting glioblastoma after radiotherapy prognosis and guiding therapy.
    Huang R; Lu X; Sun X; Wu H
    Int J Immunopathol Pharmacol; 2024; 38():3946320241249395. PubMed ID: 38687369
    [No Abstract]   [Full Text] [Related]  

  • 14. The CXCL Family Contributes to Immunosuppressive Microenvironment in Gliomas and Assists in Gliomas Chemotherapy.
    Wang Z; Liu Y; Mo Y; Zhang H; Dai Z; Zhang X; Ye W; Cao H; Liu Z; Cheng Q
    Front Immunol; 2021; 12():731751. PubMed ID: 34603309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy.
    Ji H; Ba Y; Ma S; Hou K; Mi S; Gao X; Jin J; Gong Q; Liu T; Wang F; Liu Z; Li S; Du J; Hu S
    Front Immunol; 2021; 12():729359. PubMed ID: 34566988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of beta-2 microglobulin expression on the survival of glioma patients via modulating the tumor immune microenvironment.
    Tang F; Zhao YH; Zhang Q; Wei W; Tian SF; Li C; Yao J; Wang ZF; Li ZQ
    CNS Neurosci Ther; 2021 Aug; 27(8):951-962. PubMed ID: 33960680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma.
    He J; Zeng C; Long Y
    Comput Math Methods Med; 2021; 2021():2191709. PubMed ID: 34497663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weighted gene correlation network analysis identifies microenvironment-related genes signature as prognostic candidate for Grade II/III glioma.
    Li Y; Deng G; Zhang H; Qi Y; Gao L; Tan Y; Hu P; Wang Y; Liu B; Chen Q
    Aging (Albany NY); 2020 Nov; 12(21):22122-22138. PubMed ID: 33186124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma.
    Kang K; Xie F; Wu Y; Wang Z; Wang L; Long J; Lian X; Zhang F
    Int Immunopharmacol; 2021 Jul; 96():107610. PubMed ID: 33848908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of TAMs marker genes in glioma for predicting prognosis and immunotherapy response.
    Zhao Z; Wang Z; Wu Y; Liao D; Zhao B
    Mol Immunol; 2022 Apr; 144():78-95. PubMed ID: 35203024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.